Gene therapy injected into eyes aims to halt blindness
Disease control
Recruiting now
This study is testing an experimental gene therapy drug called laruparetigene zovaparvovec. It is given as an injection into the back of both eyes of male participants with X-linked retinitis pigmentosa (XLRP), an inherited disease that causes progressive vision loss. The main go…
Phase: PHASE2 • Sponsor: Beacon Therapeutics • Aim: Disease control
Last updated Apr 16, 2026 13:01 UTC